Forty-four subjects with retrocochlear lesions were examined. Of these, 28 had acoustic neuromas, three had meningiomas and two had cholesteatomas in the cerebellopontine angle, that were all later surgically verified. One had a microglioma affecting the cerebellum and brainstem bilaterally, verified post mortem. In the remaining 10 subjects, the diagnosis was based on neuroradiologic findings (computed tomography and meatography), the clinical diagnosis being either cerebellopontine angle tumour or intra-canalicular acoustic tumour.
In evaluating auditory function, stimuli usually have been acoustically simple, such as pure tones or clicks, or very complex, such as human speech. With the purpose of trying to bridge this gap, dynamic stimuli consisting of brief frequency glides of specified duration and magnitude in a continuous pure tone were studied to obtain increased knowledge of auditory function and effects of various disorders of the auditory system. In previous reports, we have pre- sented studies where such stimuli were used to evoke auditory cortical responses from subjects with normal hearing' as well as with inner ear hearing loss. 2 In addition to the extensive studies on these limited groups of subjects, evoked auditory responses to frequency glides have been recorded in our clinic on all patients which have been seen for evaluation of unilateral sensorineural hearing loss. For many of those patients, no final diagnosis as to the site of lesion has been reached. However, one subgroup proved to be a general exception to this rule, namely those with intracranial tumours that affected auditory nerve function. Over a period of six years, auditory cortical responses-evoked by frequency glides have been recorded from 44 such patients. The results from these examinations were different from what had previously been found on other groups and will be presented in this report.
Subjects
Forty-four subjects with retrocochlear lesions were examined. Of these, 28 had acoustic neuromas, three had meningiomas and two had cholesteatomas in the cerebellopontine angle, that were all later surgically verified. One had a microglioma affecting the cerebellum and brainstem bilaterally, verified post mortem. In the remaining 10 subjects, the diagnosis was based on neuroradiologic findings (computed tomography and meatography), the clinical diagnosis being either cerebellopontine angle tumour or intra-canalicular acoustic tumour.
The subjects' ages varied from 15 to 73 years with a mean of 54 and a median of 58 years. Twenty-three of the subjects were men and 21 women. Of the 43 cases of unilateral tumour, 21 had involvement of the right and 22 of the left side. Hearing loss at 1 kHz varied over the range 5-120 dB HL with a mean of 53 dB on the tumour side. On the non-tumour side the range of hearing threshold levels at 1 kHz was -5 to 55 dB with a mean of 9 dB. All except five were within normal range (that is -20 dB). Table 1 shows the distributions of hearing threshold levels in four classes for 1 and 4 kHz. Also the distribution of speech discrimination scores is presented.
Methods
What is specific in this test is the dynamic stimulus, which is based on a continuous pure tone, the base frequency of which, f0, is usually 1 kHz (fig 1) . On three subjects, whose hearing thresholds were too poor at this frequency (110 dB HL or more), 500 Hz was used instead. The At f 50Hz Table 2 shows the incidence of response latencies falling outside the limits for both, one, or none of the two stimulus magnitudes. The difference between the present group of subjects with retrocochlear hearing impairment and the group having cochlear hearing On the eight subjects on whom were recorded evoked responses to amplitude glides in addition to the frequency glides, the results showed no significant Ni-latency difference between tumour and nontumour sides for five dB glides. For 20 dB glides stimulation on the tumour side produced response latencies that were barely significantly longer than when stimulating the non-tumour side. However, when the frequency glides were used on these particular subjects, highly significant side effects were recorded.
Auditory brainstem responses were recorded from 22 of the 44 subjects. On 12 of these (55%), an Ni-latencies in response to amplitude glides as recorded from eight of the subjects had a mean value of 158 ms on the tumour side and 134 ms on the non-tumour side for five dB glides. This difference is, however, not statistically significant. For 20 dB glides the mean latencies were 128 and 109 ms, respectively, which difference is significant (p < 0-1). However, on these particular subjects, Ni-latencies to frequency glides gave highly significant differences between tumour and non-tumour side (p < 0-001). Also Nilatencies in responses to tone pulses showed a significant side difference (p < 0 05).
Auditory fatigue was tested by means of a tone decay test on 38 of the 44 subjects. Of these, 18 were found to have no or insignificant threshold tone decay when testing the ear on the tumour side (at most 5 dB at 1 kHz and/or 30 dB at 2 kHz), while (2) reduced excitation on the tumour side due to abnormal fatigue when the ear is exposed to continuous tone stimulation (3) reduced specific sensitivity to this particular stimulus, the frequency glide. If the tumour gave rise to a general reduction of neural conduction time as the main cause of the increased Ni-latency in response to frequency glides, one would expect a similar degree of increased latency in responses to tone pulse stimulation. Such a finding was actually described by Shimizu8 in a study of four cases with acoustic neuromas. However, Townsend and Cody9 studying six subjects with the same diagnosis could not confirm this finding.
In the present study, the loud tone pulses and the 200 Hz glides produce approximately equivalent latencies, around 120 ms, when stimulating the nontumour side. On the tumour side, the sound levels of the tone pulses and the tone with frequency glides were chosen to give approximately the same loudness as those used on the non-tumour side. Also, the same rules for the use of contralateral masking were applied. Thus, if the main reason for increased latencies in response to frequency glides to the tumour side were a general reduction in neural conduction velocity, one would expect approximately the same latency increase for stimulation with the loud tone pulses and with the frequency glides of 200 Hz. This was however not found; the side difference for the Arlinger frequency glides was much larger than for the tone pulses.
It is well known that cases with acoustic neuromas often display abnormal auditory fatigue,'0 and the continuous tone used in the frequency glide stimulation could of course give rise to such fatigue and be part or all of the reason for the prolonged latencies. Thus, one would expect response latencies from subjects with abnormal auditory fatigue to be considerably longer than those recorded on subjects lacking auditory fatigue. This was however not found; the results showed that no significant difference could be proven between these two groups of subjects. This finding leads us to the conclusion that abnormal fatigue on the tumour side is not a likely explanation for the results.
This conclusion receives further support by the results from the eight subjects on whom amplitude glides of a continuous tone also were used as stimulus to evoke cortical responses. Using amplitude glides no significant side differences were found, while the frequency glides on these particular subjects gave highly significant side differences. If abnormal fatigue was the main reason for prolonged latencies on the tumour side, one would expect amplitude and frequency glides of a continuous tone to be equivalent in this respect, which was not found to be the case.
These results suggest that the tumour causes a reduction of a specific sensitivity to the frequency glide stimulation. This does not imply that the auditory nerve contains fibres that respond to the changing frequency as such, in the way that has been shown to exist in higher levels of the auditory pathways. '-' It seems more reasonable to interpret this finding as a sign of the tumour affecting the complex neural message in the auditory nerve in a way that the subsequent processing of the dynamic change in tone frequency is altered.
Another interesting issue is what functional auditory effects this prolongation of NI-latency for frequency glide stimulation may indicate. An analysis of the speech discrimination scores of the tumour ears as determined by conventional clinical testing with phonetically balanced lists of monosyllabic test words showed a large variation, from 0 to 100%, and with a tendency to bimodal distribution. Dividing the tumour group into two subgroups according to speech discrimination scores less or more than 50%, 26 ears fell into the poorer group and 19 into the better. NI-latencies to frequency glides were significantly different in the two subgroups (Wilcoxon rank test for two independent samples; p < 0 01 for 50 Hz glides, p < 0 05 for 200 Hz glides). Furthermore, linear regression analysis showed a significant correlation between speech discrimination scores and Nilatencies in response to 200 Hz glides (r = -0 54, p <
